Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : MCNS -- Ignore unavailable to you. Want to Upgrade?

To: R. Bond who wrote (1024)	10/19/1999 1:25:00 PM
From: telecomguy	Read Replies (1) \| Respond to of 1116

But even if you can count the hits, how can the Pharmaceuticals actually figure out how much sale/revenue is actually generated from the customers who find information about certain drugs from the MCNS web site? If the Pharmaceuticals can't measure the hard return on their Sponsorship investment, would that not limit the amount of revenue MCNS can demand?

To: R. Bond who wrote (1024)	10/19/1999 10:24:00 PM
From: telecomguy	Read Replies (1) \| Respond to of 1116

Mr.Bond/Mr.Berkman; I did not get your reply to my last email regarding MCNS's revenue generating capability now that they have announced 100% sponsorship business model. To me, the big question mark is whether there is enough money to be made from sponsorship to generate the kind of share price appreciation that Amazon/Ebay etc. has experienced. What is it that MCNS does better than 100's of other Medical web pages that the Pharmaceuticals would be compelled to throw hundreds of millions of $ in sponsorship fees UNLESS they felt that somehow sponsoring MCNS would generate huge drug sales for THEIR product? If MCNS revenue is not generated by TRANSACTION PROCESSING off their web site, I am concerned that MCNS will NOT generate enough new business for the Pharamceuticals that is needed to justify huge sponsorship fees regardless of how many "sticky" hits MCNS generates.